Our research underscores the varying levels of TLR2 and TLR4 expression in gliomas and epilepsy, with TLR2 showing a significant increase in HGGs and both TLRs exhibiting marked elevation in epilepsy tissues compared to LGGs. Here, TLR2 is linked to central nervous system cancer.